Home › Stocks › BXRX

BXRX — BAUDAX BIO INC

Reported value held$531.00K
Funds holding (latest)10
Sector—

BXRX (BAUDAX BIO INC) is tracked on HoldingsHub across five years of quarterly 13F filings. 10 funds have reported positions historically, with the sum of their latest reported stakes valued at $531.00K. No fund in our coverage reported a position in the latest filing period, which typically means the stock has fallen out of the tracked funds' portfolios rather than that it cannot be bought.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

FundQuarterSharesValuePortfolio WeightChange
D. E. Shaw & Co history Q1 2022 234.97K $416.00K 0.00% New
Renaissance Technologies history Q3 2022 241.52K $59.00K 0.00% Reduce
UBS Group AG history Q3 2022 77.34K $19.00K 0.00% Add
Geode Capital Management history Q3 2022 65.58K $16.00K 0.00% Hold
Vanguard Group history Q3 2022 58.32K $14.00K 0.00% Reduce
Millennium Management history Q3 2022 25.90K $6.00K 0.00% New
Morgan Stanley history Q3 2022 5.39K $1.00K 0.00% Add
JPMorgan Chase & Co history Q3 2022 14 $0 — Hold
Citigroup Inc history Q2 2022 30 $0 — Reduce
Wells Fargo & Co history Q3 2022 56 $0 — Add

New Positions (latest)

No fund opened a new position this quarter.

Fully Exited (vs previous quarter)

No tracked fund fully exited this quarter.

Fund Position History — shares by quarter (top 10 funds)

FundQ1 2022Q2 2022Q3 2022
Renaissance Technologies 237.30K 320.17K 241.52K
UBS Group AG — 7.13K 77.34K
Geode Capital Management 59.55K 65.58K 65.58K
Vanguard Group 126.33K 59.38K 58.32K
Millennium Management — — 25.90K
Morgan Stanley 1.32K 860 5.39K
JPMorgan Chase & Co 144 14 14
Citigroup Inc 757 30 —
D. E. Shaw & Co 234.97K — —
Wells Fargo & Co 17 45 56

Download holders (CSV)